The global electrophysiology (EPY) market is mainly driven by an increase in invasive electrophysiological (EP) testing and catheter ablation procedures across the world. The rising prevalence of congenital diseases and the growing number of people with implantable cardioverter-defibrillator (ICD) are factors that have stimulated electrophysiology studies (EPS). Ultimately it enhancing the growth of the electrophysiology market. For instance, in 2017, one study was conducted in Fatima University Medical Center, Philippines, where 12 lead electrocardiogram and the 2D echo was involved. Echocardiography-derived left ventricular ejection fraction among patients.
Furthermore, the electrophysiology market is expanded due to growth in the ageing population as well as an increasing number of adults with high blood pressure. Also, notable technological progress has been seen in the equipment’s for example, A C-arm is an imaging scanner intensifier. Hence, specialized EP equipment has improved the growth of the electrophysiology market.
However, a lack of skilled & experienced electrophysiologists is hindering the growth of the market. Besides, developments in data acquisition systems by equipment manufacturers will open new ways for market’s growth in the forthcoming years.
Electrophysiology Market Segment Overview
EP Laboratory Devices are enhancing the market owing to increasing improvement and modernization of healthcare infrastructure. Also, growth in affordable electrophysiology devices is boosting the demand for EP devices in the global electrophysiology markets. Additionally, market players are increasingly focusing on the launch of new technologically advanced devices. For instance, in August 2018, BioSig Technologies received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA).
Over the past few years, techniques for the placement of catheters have improved significantly. Also, the indications of EPS are diverse as the genesis are complex. These key facts driving the growth of the electrophysiology market.
Electrophysiology Regional Overview
North America accounts for a major share in the electrophysiology market followed by Europe. This is due to the presence of technically advance healthcare infrastructure in the region. In addition, the Asia Pacific is expected to show rapid growth with a gradual increase in market share. This is on account of increasing healthcare expenditure and developments in healthcare infrastructure in the emerging economies in this region.
Electrophysiology Market Competitor overview
· In March 2020, Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the Genesis RMN® System for the robotic navigation of magnetic ablation catheters to treat heart rhythm disorders.
· In June 2019, the global humanitarian organization CARE, the healthcare company Abbott and its foundation the Abbott Fund announced partnership, a three-year $1 million program to screen, diagnose, prevent and manage noncommunicable diseases (NCDs) for people who remain displaced two years after armed conflict in Marawi City, Philippines.
· In January 2019, Medtronic plc announced that it has entered into a definitive agreement to acquire EPIX Therapeutics, Inc. (EPIX), a privately-held medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias, including atrial fibrillation (AF). When completed, the EPIX acquisition will expand the Medtronic cardiac ablation portfolio to offer physicians a comprehensive suite of tools to treat patients with cardiac arrhythmias.
Electrophysiology Market, Key Players
· Schwarzer Cardiotek GmbH
· Siemens Healthineers
· Merit Medical Systems
· TZ Medical
· Lepu Medical
· Epmap-System
· CathVision
· CardioFocus
· EP Solutions
· Imricor Medical Systems
· MicroPort Scientific Corporation
· GE Healthcare
· Medtronic
· Abbott Laboratories
· Boston Scientific
· Johnson & Johnson.
Electrophysiology Market Segmentation
Electrophysiology Market, By Product
· EP Ablation Catheters
· EP Laboratory Devices
· EP Diagnostic Catheters
· Access Devices
· Others
Electrophysiology Market, By Indication
· Atrial Fibrillation
· Atrial Flutter
· Atrioventricular Nodal Reentry Tachycardia
· Wolff-Parkinson-White Syndrome
· Other Indications
Electrophysiology Market, By End User
· Hospitals & Cardiac Centers
· Ambulatory Surgery Centers
Electrophysiology market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. EP Ablation Catheters
- 5.2.2. EP Laboratory Devices
- 5.2.3. EP Diagnostic Catheters
- 5.2.4. Access Devices
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Indication
- 5.3.1. Atrial Fibrillation
- 5.3.2. Atrial Flutter
- 5.3.3. Atrioventricular Nodal Reentry Tachycardia
- 5.3.4. Wolff-Parkinson-White Syndrome
- 5.3.5. Other Indications
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals & Cardiac Centers
- 5.4.2. Ambulatory Surgery Centers
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. EP Ablation Catheters
- 6.2.2. EP Laboratory Devices
- 6.2.3. EP Diagnostic Catheters
- 6.2.4. Access Devices
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By Indication
- 6.3.1. Atrial Fibrillation
- 6.3.2. Atrial Flutter
- 6.3.3. Atrioventricular Nodal Reentry Tachycardia
- 6.3.4. Wolff-Parkinson-White Syndrome
- 6.3.5. Other Indications
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals & Cardiac Centers
- 6.4.2. Ambulatory Surgery Centers
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. EP Ablation Catheters
- 7.2.2. EP Laboratory Devices
- 7.2.3. EP Diagnostic Catheters
- 7.2.4. Access Devices
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By Indication
- 7.3.1. Atrial Fibrillation
- 7.3.2. Atrial Flutter
- 7.3.3. Atrioventricular Nodal Reentry Tachycardia
- 7.3.4. Wolff-Parkinson-White Syndrome
- 7.3.5. Other Indications
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals & Cardiac Centers
- 7.4.2. Ambulatory Surgery Centers
- 7.5. Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. EP Ablation Catheters
- 8.2.2. EP Laboratory Devices
- 8.2.3. EP Diagnostic Catheters
- 8.2.4. Access Devices
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By Indication
- 8.3.1. Atrial Fibrillation
- 8.3.2. Atrial Flutter
- 8.3.3. Atrioventricular Nodal Reentry Tachycardia
- 8.3.4. Wolff-Parkinson-White Syndrome
- 8.3.5. Other Indications
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals & Cardiac Centers
- 8.4.2. Ambulatory Surgery Centers
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. EP Ablation Catheters
- 9.2.2. EP Laboratory Devices
- 9.2.3. EP Diagnostic Catheters
- 9.2.4. Access Devices
- 9.2.5. Others
- 9.2.6. Fluid Management Systems
- 9.3. Market Analysis, Insights and Forecast – By Indication
- 9.3.1. Atrial Fibrillation
- 9.3.2. Atrial Flutter
- 9.3.3. Atrioventricular Nodal Reentry Tachycardia
- 9.3.4. Wolff-Parkinson-White Syndrome
- 9.3.5. Other Indications
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals & Cardiac Centers
- 9.4.2. Ambulatory Surgery Centers
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Electrophysiology Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. EP Ablation Catheters
- 10.2.2. EP Laboratory Devices
- 10.2.3. EP Diagnostic Catheters
- 10.2.4. Access Devices
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By Indication
- 10.3.1. Atrial Fibrillation
- 10.3.2. Atrial Flutter
- 10.3.3. Atrioventricular Nodal Reentry Tachycardia
- 10.3.4. Wolff-Parkinson-White Syndrome
- 10.3.5. Other Indications
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Hospitals & Cardiac Centers
- 10.4.2. Ambulatory Surgery Centers
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Schwarzer Cardiotek GmbH
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Siemens Healthineers
- 11.6. Merit Medical Systems
- 11.7. TZ Medical
- 11.8. Lepu Medical
- 11.9. Epmap-System
- 11.10. CathVision
- 11.11. CardioFocus
- 11.12. EP Solutions
- 11.13. Imricor Medical Systems
- 11.14. MicroPort Scientific Corporation
- 11.15. GE Healthcare
- 11.16. Medtronic
- 11.17. Abbott Laboratories
- 11.18. Boston Scientific
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
